Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea flag South Korea · Delayed Price · Currency is KRW
52,900
-100 (-0.19%)
Aug 8, 2025, 3:30 PM KST

Beacon Roofing Supply Revenue

Celltrion Pharm had revenue of 85.55B KRW in the quarter ending March 31, 2021, with 92.73% growth. This brings the company's revenue in the last twelve months to 274.73B, up 53.21% year-over-year. In the year 2020, Celltrion Pharm had annual revenue of 233.57B with 34.61% growth.

Revenue (ttm)
274.73B
Revenue Growth
+53.21%
P/S Ratio
8.39
Revenue / Employee
837.59M
Employees
328
Market Cap
2,305.21B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2020233.57B60.06B34.61%
Dec 31, 2019173.51B26.63B18.13%
Dec 31, 2018146.88B11.02B8.11%
Dec 31, 2017135.86B31.05B29.62%
Dec 31, 2016104.81B30.08B40.25%
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
Yuhan2,114.76B
SK Biopharmaceuticals578.00B
Peptron4.30B
HLB Co., Ltd.74.64B
PharmaResearch392.31B
Revenue Rankings